Correction: Flammang et al. Tumor-Suppressive miR-192-5p Has Prognostic Value in Pancreatic Ductal Adenocarcinoma. Cancers 2020, 12, 1693
1. Missing Funding
2. Addition of an Author
Author Contributions
Funding
Reference
- Flammang, I.; Reese, M.; Yang, Z.; Eble, J.A.; Dhayat, S.A. Tumor-Suppressive miR-192-5p Has Prognostic Value in Pancreatic Ductal Adenocarcinoma. Cancers 2020, 12, 1693. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Flammang, I.; Reese, M.; Ströse, A.J.; Yang, Z.; Eble, J.A.; Dhayat, S.A. Correction: Flammang et al. Tumor-Suppressive miR-192-5p Has Prognostic Value in Pancreatic Ductal Adenocarcinoma. Cancers 2020, 12, 1693. Cancers 2024, 16, 2825. https://doi.org/10.3390/cancers16162825
Flammang I, Reese M, Ströse AJ, Yang Z, Eble JA, Dhayat SA. Correction: Flammang et al. Tumor-Suppressive miR-192-5p Has Prognostic Value in Pancreatic Ductal Adenocarcinoma. Cancers 2020, 12, 1693. Cancers. 2024; 16(16):2825. https://doi.org/10.3390/cancers16162825
Chicago/Turabian StyleFlammang, Isabelle, Moritz Reese, Anda J. Ströse, Zixuan Yang, Johannes A. Eble, and Sameer A. Dhayat. 2024. "Correction: Flammang et al. Tumor-Suppressive miR-192-5p Has Prognostic Value in Pancreatic Ductal Adenocarcinoma. Cancers 2020, 12, 1693" Cancers 16, no. 16: 2825. https://doi.org/10.3390/cancers16162825